Ensysce Biosciences, Inc.

Lux Health Tech Acquisition Corp, trading on Nasdaq under the ticker LACQ, completed its initial public offering in 2020 with Lux Capital serving as sponsor, targeting the healthcare and life sciences sector. The company filed an 8-K with the SEC on February 2, 2021, disclosing developments related to its proposed business combination with Ensysce Biosciences, Inc., a pharmaceutical company focused on developing abuse-deterrent opioid formulations and real-time drug monitoring technology. The transaction represented a key step in Ensysce's path toward a public listing through the SPAC structure. Sign up at SpacDesk for full filing histories, deal timelines, and analytics across the entire SPAC universe.